| Literature DB >> 29279573 |
Shinya Iguchi1, Daigo Suzuki1, Eisuke Kawano1, Takayuki Mashimo2, Mikihito Kajiya3, Taku Toriumi4,5, Toshihisa Kawai6, Hidemi Kurihara3, Keitaro Isokawa4,5, Shuichi Sato7,8, Masaki Honda9.
Abstract
Bone marrow-derived multipotent stromal cells (BMSCs) have potent antiinflammatory effects. This study aimed to investigate the antiinflammatory potential of BMSCs using a mouse model of ligature-induced periodontitis. BMSCs were isolated from the femurs and tibiae of mice. Periodontitis was induced by placing a ligature around the right maxillary second molar. After 3 days, the mice were administered BMSC in the gingiva of the mesial interdental papilla around the ligatured molar. The ligatured and non-ligatured mice that were not administered BMSC served as controls. Differences in inflammatory infiltration and bone resorption around the roots of the second molar were assessed and were subsequently quantified using microcomputed tomography (micro-CT), histological analysis, and tartrate-resistant acid phosphatase (TRAP) staining. Micro-CT revealed that alveolar bone loss around the ligatured molars increased in a time-dependent manner; however, the effect was significantly less in BMSC-treated mice compared with ligatured control mice. Tissue histopathology revealed that BMSC administration mitigated inflammatory infiltration in ligatured BMSC mice. In addition, the number of TRAP-positive osteoclasts was markedly elevated in ligatured control mice compared with those in BMSC-treated mice. These findings indicate that local BMSC administration can mitigate inflammation and alveolar bone resorption, suggesting that administering BMSC leads to new therapeutics for periodontitis.Entities:
Keywords: bone marrow stromal cell; bone resorption; cell therapy; local administration; periodontitis
Mesh:
Year: 2017 PMID: 29279573 DOI: 10.2334/josnusd.16-0033
Source DB: PubMed Journal: J Oral Sci ISSN: 1343-4934 Impact factor: 1.556